WDA Licence in London
Obtaining a Wholesale Dealer’s Authorisation (WDA) is essential for pharmaceutical and biotechnology companies in London to legally store, supply and distribute medicinal products.
This process demands strict adherence to Good Distribution Practice (GDP) and compliance with rigorous regulatory standards. At Inglasia, we provide comprehensive support to help companies secure and maintain their WDA licence, ensuring compliance and upholding the highest standards of quality and safety.
What is a WDA Licence?
A WDA licence permits the wholesale distribution of medicinal products in the UK. It requires entities to meet stringent guidelines, ensuring product quality and safe delivery to patients.
Why is the WDA Licence Crucial for Pharmaceutical Companies in London?
The UK enforces stringent requirements for medicinal distribution, with GDP as a core part of WDA licensing. Without a WDA licence, companies cannot legally distribute pharmaceuticals, risking severe penalties and reputational damage. A WDA licence assures stakeholders that products meet high-quality standards, safeguarding public health.
The Key Role of Good Distribution Practice (GDP)
Good Distribution Practice (GDP) underpins WDA licence requirements, ensuring pharmaceutical products are consistently stored, transported and handled to protect quality. GDP compliance includes:
- Controlled storage and transportation: Maintains products within set temperature and humidity ranges.
- Comprehensive documentation: Tracks each distribution step for full traceability.
- Risk management: Identifies and mitigates risks to protect product integrity.
We specialise in helping pharmaceutical companies implement GDP-compliant processes that meet these requirements, supporting clients from initial application through successful inspections.
Our Comprehensive WDA Licence Support Services
Securing a WDA licence in London demands careful preparation and regulatory expertise. We guide pharmaceutical and biotechnology companies through every step, from initial consultations to ongoing compliance. Here’s how we help:
Pre-Application Guidance and Consultation
Our consultants provide initial guidance on WDA licence requirements and assess current operations. We conduct gap analyses to identify needed documentation, process improvements or training, ensuring clients are fully prepared for the application.
Quality Management System (QMS) Implementation
An effective Quality Management System (QMS) is essential for GDP compliance. We assist companies in designing and implementing a QMS that meets the standards required for a WDA licence. Our QMS services include:
- Developing and documenting standard operating procedures (SOPs)
- Setting up effective monitoring and reporting systems
- Ensuring all processes align with GDP standards
Training and Development
Maintaining a WDA licence requires continuous GDP compliance. We offer training for all employees, from warehouse staff to managers, ensuring everyone understands their role in product safety and quality. Our training includes:
- GDP fundamentals and their application in daily operations
- Handling and documentation requirements
- Risk management and response strategies
Mock Inspections and Audit Support
We conduct mock inspections to help clients prepare for MHRA reviews. Our GMP- and GDP-trained auditors perform comprehensive assessments, enabling proactive compliance issue resolution.
Ongoing Compliance Monitoring
After obtaining the WDA licence, companies must continuously uphold GDP standards. We provide ongoing compliance support with audits, regulatory updates and deviation management to keep clients fully compliant and inspection-ready.
Responsible Person (RP) and Responsible Person for Import (RPi)
At Inglasia, we recognise the importance of ensuring full compliance with the UK’s WDA requirements. Our team of seasoned Quality and Regulatory experts provides comprehensive services tailored to meet the needs of pharmaceutical businesses navigating the complexities of WDA licensure in London.
A critical aspect of maintaining a WDA licence is the designation of Responsible Persons (RP) and Responsible Persons for Import (RPi). These individuals play pivotal roles in ensuring compliance with GDP and safeguarding the integrity of medicines throughout the supply chain.
Our experts are qualified to be named as RP and RPi on your WDA licence, delivering end-to-end support for:
- Compliance audits and risk assessments against EU and UK GDP standards.
- Development and management of inspection-ready QMS.
- Writing site master files and quality manuals.
- Providing ongoing training on GDP compliance for staff.
By partnering with us, you can streamline your licensing process and maintain compliance with regulatory obligations while focusing on your core business operations.
Why Choose Us for Your WDA Licence in London?
We stand out for our expertise and dedication to helping pharmaceutical companies achieve and maintain compliance. Our team of industry veterans understands GMP and GDP regulations, offering clients:
- Bespoke solutions: Tailored services that address the unique challenges of each client
- Expert guidance: Advisors who stay updated on regulatory changes and industry trends
- End-to-end support: Comprehensive assistance from application to post-licence compliance
Obtaining a WDA licence in London is challenging, but with the right support, companies can confidently meet regulatory requirements. We ensure
Partner with Us
For expert guidance on WDA licence compliance, reach out by completing our online contact form or emailing info@inglasia.com. Let us support your journey toward meeting regulatory standards with confidence.